New drug GEn-1124 tested in just 6 men – first look at how body handles it
Knowledge-focused
Completed
This early-phase study tested a single oral dose of GEn-1124 in 6 healthy adult men. Researchers measured how the drug moves through the body and checked for any side effects. Participants stayed in the clinic for 2 days and received follow-up phone calls. The goal was to gather …
Phase: PHASE1 • Sponsor: GEn1E Lifesciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC